GO
| HSI1 | 24,498.95 | -18.81 | 236.41B |
| HSCEI1 | 8,853.10 | -8.29 | 74.68B |
| Back Zoom + Zoom - Block Traded | |
|
2025-07-17 10:33:55 UBS published a research report expecting HKEX (00388.HK)'s 2Q25 NPAT/ revenue to increase 35%/ 30% to $4.3 billion/ $7 billion each, 11%/ 7% higher than market consensus, mainly due to better-than-expected net investment income (NII). The broker anticipated full-year NPAT/ revenue to rise by 16% YoY to $15 billion/ $30 billion. UBS also raised its 2025/ 2026/ 2027 ADT forecasts by 14%/ 9%/ 8% to $218 billion/ $185 billion/ $208 billion, and EPS forecasts by 5%/ 2%/ 4% to $11.9/ $10.5/ $11.5, respectively. Therefore, the broker elevated its target price from $393 to $430, with rating kept at Neutral. ~ AASTOCKS Financial News Website: www.aastocks.com | |